Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 39,407 | 36,243 | 32,962 | 28,759 | 27,742 |
| Gross Profit | 39,407 | 36,243 | 32,962 | 28,759 | 27,742 |
| Operating Expenses | 16,515 | 15,342 | 11,274 | 11,839 | 9,226 |
| Operating Income | 22,892 | 20,901 | 21,688 | 16,920 | 18,516 |
| Interest Expense | 5,936 | 5,336 | 4,300 | 3,529 | 2,974 |
| Other Income | 5 | 6 | 2 | 1 | 3 |
| Pre-tax Income | 16,961 | 15,571 | 17,390 | 13,392 | 15,545 |
| Income Tax | 2,505 | 2,648 | 3,585 | 2,301 | 2,550 |
| Net Income Continuous | 14,456 | 12,923 | 13,805 | 11,091 | 12,995 |
| Minority Interests | 65 | 32 | 183 | 211 | 199 |
| Net Income | $14,391 | $12,891 | $13,622 | $10,880 | $12,796 |
| EPS Basic Total Ops | 0.75 | 0.67 | 0.71 | 0.56 | 0.66 |
| EPS Basic Continuous Ops | 0.75 | 0.67 | 0.72 | 0.57 | 0.67 |
| EPS Diluted Total Ops | 0.73 | 0.65 | 0.70 | 0.55 | 0.65 |
| EPS Diluted Continuous Ops | 0.73 | 0.66 | 0.71 | 0.56 | 0.66 |
| EBITDA(a) | $34,518 | $32,606 | $31,022 | $25,129 | $26,021 |